PROBIODRUG GES FUER ARZNEIM has a total of 35 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are POTISEK STEPHANIE L, MOSKAL JOSEPH and BACHOVCHIN WILLIAM W.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Brazil | 4 | |
#4 | Canada | 3 | |
#5 | Czechia | 3 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Hungary | 2 | |
#9 | Norway | 2 | |
#10 | Israel | 1 | |
#11 | Mexico | 1 | |
#12 | Poland | 1 | |
#13 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Macromolecular chemistry and polymers | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Unspecified technologies | |
#6 | Special macromolecular compounds |
# | Name | Total Patents |
---|---|---|
#1 | Demuth Hans-Ulrich | 31 |
#2 | Schlenzig Dagmar | 16 |
#3 | Hoffmann Torsten | 16 |
#4 | Glund Konrad | 15 |
#5 | Kruber Susanne | 10 |
#6 | Schmidt Joern | 7 |
#7 | Manhart Susanne | 6 |
#8 | Heiser Ulrich | 3 |
#9 | Rosche Fred | 2 |
#10 | Mcintosh Christopher H S | 1 |
Publication | Filing date | Title |
---|---|---|
DE19940130A1 | New effectors of Dipeptidyl Peptidase IV for topical use | |
CZ20004796A3 | Compounds of unstable DP IV-inhibitors | |
CZ20004764A3 | Precursors of DP IV-inhibitors | |
DE19926233C1 | Production of thiazolidine, useful as pharmaceutical intermediate, comprises reacting hexamethylenetetramine with cysteamine | |
CZ20004427A3 | Novel effectors of IV dipeptidyl peptidase | |
DE19834591A1 | Use of substances that decrease the activity of dipeptidyl peptidase IV to increase blood sugar levels, e.g. for treating hypoglycemia | |
DE19834610A1 | New N-dipeptidyl O-acyl hydroxylamine derivatives useful as dipeptidyl peptidase I inhibitors, e.g. for treating cancer or immunological or metabolic disorders | |
DE19828113A1 | Prodrugs of Dipeptidyl Peptidase IV Inhibitors | |
DE19828114A1 | Produgs of unstable inhibitors of dipeptidyl peptidase IV | |
DE19823831A1 | New pharmaceutical use of isoleucyl thiazolidide and its salts |